Results 51 to 60 of about 859,888 (229)

Transcatheter treatment for tricuspid valve disease. [PDF]

, 2021
Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve apparatus and is observed in only 8-10% of the patients with tricuspid valve ...
Maisano, Francesco, Praz, F., Kreidel, F., Mangieri, A., Prendergast, B.D., Muraru, Denisa, Hahn, Rebecca T, Zamorano, Jose L, Mangieri, Antonio, Zamorano, J.L., von Bardeleben, Ralph Stephan, Hausleiter, Jörg, Maisano, F., Nickenig, G., Prendergast, Bernard D, Bardeleben, R.S. von, Senni, Michele, Nickenig, Georg, Delgado, V., Praz, Fabien, Lurz, P., Senni, M., Delgado, Victoria, Hausleiter, J., Lurz, Philipp, Hahn, R.T., Kreidel, Felix, Muraru, D., Felix Kreidel, Philipp Lurz, Michele Senni, Jörg Hausleiter, Fabien Praz, Rebecca T. Hahn, Ralph Stephan von Bardeleben, Denisa Muraru, Jose L. Zamorano, Antonio Mangieri, Bernard D. Prendergast, Victoria Delgado, Francesco Maisano, Georg Nickenig   +41 more
core   +2 more sources

Transcatheter edge‐to‐edge tricuspid repair for recurrence of valvular regurgitation after left ventricular assist device and tricuspid ring implantation

ESC Heart Failure, 2020
Tricuspid regurgitation in patients with left ventricular assist device (LVAD) has a significant impact on prognosis and quality of life, and its effects on liver and renal function could negatively impact planned heart transplantation.
Martin Andreas, Marco Russo, Paul Werner, Matthias Schneider, Franziska Wittmann, Sabine Scherzer, Julia Mascherbauer, Alfred Kocher, Guenther Laufer, Dominik Wiedemann, Daniel Zimpfer   +10 more
doaj   +1 more source

Transcatheter therapies for tricuspid valve regurgitation

, 2020
: Tricuspid regurgitation, either isolated or associated with left-valve disease, has a strong impact on outcome. Surgical treatment of tricuspid regurgitation has increased in recent years, but in-hospital mortality remains high probably due to the risk
Fiorina C., Metra M., Adamo M., Zaccone G., Di Pasquale M., Curello S.   +5 more
core   +1 more source

Heterotopic Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation and Refractory Right Heart Failure

, 2022
Torrential tricuspid regurgitation may lead to heart failure and poor survival and quality of life. Heterotopic transcatheter tricuspid replacement is increasingly offered to patients unsuitable for direct valve repair or replacement.
Stazzoni, Laura, Marco De Carlo, De Carlo, Marco, Angelillis, Marco, Roberto Del Sorbo, Laura Stazzoni, Daniele Bozzoli, Bozzoli, Daniele, Giannini, Cristina, Anna Sonia Petronio, Del Sorbo, Roberto, Cristina Giannini, Spontoni, Paolo, Petronio, Anna Sonia, Paolo Spontoni, Marco Angelillis, Costa, Giulia, Giulia Costa   +17 more
core   +1 more source

Transcatheter Tricuspid Valve Therapy: From Anatomy to Intervention

Frontiers in Cardiovascular Medicine, 2021
Nowadays, severe symptomatic tricuspid regurgitation (TR) affects millions of persons worldwide. However, the benefit of surgical correction of isolated secondary TR remains controversial because of the increased risk of periprocedural mortality and ...
Valeria Cammalleri, Myriam Carpenito, Maria Caterina Bono, Simona Mega, Gian Paolo Ussia, Francesco Grigioni   +5 more
doaj   +1 more source

Imaging and Patient Selection for Transcatheter Tricuspid Valve Interventions. [PDF]

, 2020
With the emergence of transcatheter solutions for the treatment of tricuspid regurgitation (TR) increased attention has been directed to the once neglected tricuspid valve (TV) complex.
Brugger, Nicolas, Windecker, Stephan, Billinger, Michael, Praz, Fabien, Winkel, Mirjam G., Hahn, Rebecca T, Khalique, Omar K, Pilgrim, Thomas, Gräni, Christoph, Huber, Adrian, Brugger N, Billinger M, Winkel MG, Windecker S, Pilgrim T, Hahn RT, Gräni C, Khalique OK, Praz F, Huber A   +19 more
core   +2 more sources

Transcatheter Tricuspid Valve Repair With the PASCAL System

JACC: Cardiovascular Interventions, 2018
An 82-year-old woman presented with advanced right heart failure, recurrent hospitalizations, and secondary tricuspid regurgitation (TR). She had persistent New York Heart Association functional class IV dyspnea, severe fatigue, ascites, and peripheral edema.
Neil P, Fam, Edwin C, Ho, Mohammed, Zahrani, Sondos, Samargandy, Kim A, Connelly   +4 more
openaire   +2 more sources

Multi-Modality Imaging of the Tricuspid Valve: From Tricuspid Valve Disease to Catheter-Based Interventions

Reviews in Cardiovascular Medicine, 2022
Tricuspid valve disease represents a major health problem that affects a wide proportion of heart failure patients with a significant prognostic impact.
Fabio Fazzari, Francesco Cannata, Matteo Maurina, Renato Maria Bragato, Marco Francone   +4 more
doaj   +1 more source

Ventricular Interaction and Clinical Outcomes in Patients Undergoing Transcatheter Tricuspid Valve Repair.

JACC: Cardiovascular Interventions
BACKGROUND Tricuspid regurgitation (TR) causes right ventricular volume overload, which can negatively affect left ventricular (LV) hemodynamic status through ventricular interaction.
Tetsu Tanaka, A. Sugiura, Can Öztürk, Sebastian Zimmer, G. Nickenig, M. Weber, J. Vogelhuber   +6 more
semanticscholar   +2 more sources

Percutaneous Treatment of Severe Aortic Regurgitation After Surgical Mitral Valve Repair

JACC: Case Reports, 2023
A 54-year-old woman who had recently undergone surgical mitral and tricuspid valve repair was diagnosed with severe aortic regurgitation. She was scheduled for percutaneous treatment and underwent successful transcatheter aortic valve implantation with a
Evelina Toscano, MD, Mahmoud Saad Ahmed, MBBS, Kush P. Patel, MD, Thomas Treibel, MD, Simon Kennon, MD, Andreas Baumbach, PhD   +5 more
doaj   +1 more source